Amdocs Reports Q2 2025 Financial Results
Ticker: DOX · Form: 6-K · Filed: May 8, 2025 · CIK: 1062579
| Field | Detail |
|---|---|
| Company | Amdocs LTD (DOX) |
| Form Type | 6-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-results, filing
TL;DR
Amdocs dropped Q2 2025 earnings on May 7th, check the 6-K for deets.
AI Summary
On May 7, 2025, Amdocs Limited announced its financial results for the quarter ended March 31, 2025. The company issued a press release and accompanying presentation, furnished as exhibits to this Form 6-K filing.
Why It Matters
This filing provides investors with the latest financial performance data for Amdocs, crucial for understanding the company's current operational health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial results filing and does not contain new material risks.
Key Players & Entities
- Amdocs Limited (company) — Filer of the report
- March 31, 2025 (date) — End of the financial quarter reported
- May 7, 2025 (date) — Date of the press release and filing
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report Amdocs Limited's financial results for the quarter ended March 31, 2025, via a press release and accompanying presentation.
When did Amdocs Limited issue the press release regarding its financial results?
Amdocs Limited issued the press release on May 7, 2025.
What financial period do the reported results cover?
The reported results cover the quarter ended March 31, 2025.
What exhibits are furnished with this Form 6-K?
Exhibits 99.1 (press release) and 99.2 (presentation) are furnished with this Form 6-K.
What is Amdocs Limited's principal executive office address in the US?
Amdocs, Inc.'s principal executive offices are located at 625 Maryville Centre Drive, Suite 200, Saint Louis, Missouri 63141.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 8, 2025 regarding AMDOCS LTD (DOX).